Cardiovascular Devices Market Size, Share, Opportunities, And Trends By Product (Stents, Pacemakers, Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy Devices, Other Devices), By Application (Coronary Artery Diseases, Cardiac Arrhythmia, Heart Failure, Other Applications), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2025 To 2030

  • Published : Apr 2025
  • Report Code : KSI061611145
  • Pages : 148
excel pdf power-point

Cardiovascular Devices Market Size:

The Cardiovascular Devices Market is projected to grow at a CAGR of 6.68% to reach US$79.951 billion in 2030 from US$57.877 billion in 2025.

Rising cases of cardiovascular diseases (CVDs) and their severity, resulting in a surging death rate among patients, are driving global cardiovascular device market growth. Increasing expenditure on the healthcare sector and infrastructure development by the government are also contributing to this market growth. Technological innovation in the industry is leading to increased automation and inventions for early and better diagnosis, prevention, and treatment to reduce life threats, significantly expanding the market size. Furthermore, the growing aged population and increasing complexities of lifestyle are elevating the risk of CVDs, broadening the market scope for cardiovascular devices.

Cardiovascular Devices Market Growth Drivers:

Rising CVD cases are fueling global cardiovascular device market growth during the forecast period. A World Health Organization (WHO) report estimates that approximately 17.7 million people die annually from CVDs, accounting for 31% of global deaths, with the majority due to heart attacks and strokes.

An increase in the aged population is significantly supporting this market growth. WHO projects that this demographic will exceed 1.5 billion by 2050 due to low fertility rates and changing lifestyles. Rising cases are heightening government concerns and expenditure, increasing demand for cardiovascular devices for diagnosis and treatment.

Increasing government expenditure on the healthcare sector is creating new market opportunities for the industry during the forecast period. This expenditure is a key driver, as CVDs are raising death rates and reducing life expectancy, prompting governments to adopt measures for early detection and improved treatment.

Growing work culture complexities, accompanied by a hectic lifestyle, are increasing the chances of CVDs among adults aged 34 to 64. An unfavorable, imbalanced diet is contributing to unhealthy living, making people more prone to CVDs and other diseases. Genetic prevalence of these conditions may also lead to their occurrence despite precautions. Thus, a rising standard of living is encouraging regular health checks for early detection and preventive measures, notably contributing to the market size.

Cardiovascular Devices Market Geographical Outlook:

The Asia Pacific cardiovascular device market is showing robust growth potential during the forecast period owing to a surge in medical tourism. Industry analysis forecasts exponential growth in this region, significantly increasing its market share. The primary driver is the growth in medical tourism, with the Asia Pacific offering quality medical services at affordable prices, particularly for North American, European, and Middle Eastern patients. India, Singapore, South Korea, Thailand, and Malaysia are leading providers of cost-effective medical services.

The global cardiovascular devices market report deep dives into the global industry landscape and provides strategic and executive-level insights complemented by data-driven analysis and forecasts. The report is updated regularly to help the decision-makers with actionable intelligence into the current market trends, emerging opportunities, and competitive intelligence.  It explores the demand for different types of cardiovascular devices, such as stents, pacemakers, and implantable cardioverter-defibrillators, and their adoption across various geographies. The latest technological advancements in the cardiovascular devices sector, along with key government policies and regulations and macroeconomic factors, are also analyzed to present a holistic view of the market. 

Cardiovascular Devices Market Segmentation:

Cardiovascular Devices Market Segmentation by device type:

The cardiovascular devices market is analyzed by device type into the following:

  • Stents
  • Pacemakers
  • Implantable Cardioverter-Defibrillators (ICDs)
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Other Devices

Cardiovascular Devices Market Segmentation by application:

The report analyzed the cardiovascular devices market across diverse applications as follows:

  • Coronary Artery Diseases
  • Cardiac Arrhythmia
  • Heart Failure
  • Other Applications

Cardiovascular Devices Market Segmentation by end-user:

The report analyzes the cardiovascular devices market by end-user segment as below:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Cardiovascular Devices Market Segmentation by regions:

The study also analyzed the cardiovascular devices market into the following regions, with country-level forecasts and analysis as below:

  • North America (USA, Canada, and Mexico)
  • South America (Brazil, Argentina, and Others)
  • Europe (UK, Germany, France, Spain, and Others)
  • Middle East and Africa (Saudi Arabia, UAE, and Others)
  • Asia Pacific (China, Japan, India, South Korea, Taiwan, Thailand, Indonesia, and Others)

Cardiovascular Devices Market Competitive Landscape:

The cardiovascular devices market is marked by the presence of key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edwards Lifesciences Corporation, and Cardinal Health, among others.

Cardiovascular Devices Market Report Coverage:

This report provides extensive coverage as explained in the points below:

  • Cardiovascular devices market size, forecasts, and trends by different type of devices. The section provides historical revenue data with analysis focusing on key factors driving the adoption, current challenges faced by key market players and what are the major growth areas. 
  • Cardiovascular devices market size, forecasts, and trends by application, with historical revenue data and analysis of sales based on applications.
  • Cardiovascular devices market size, forecasts, and trends by end-user. The section provides historical revenue data with analysis focusing on major end-user segments.
  • Cardiovascular devices market is also analyzed across different regions, with historical data, regional share, attractiveness, and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario, and other complementary factors aiding in market growth.
  • Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model. 
  • Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge. 
  • Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented. 

How this report is helpful to you and reasons for purchase?

  • The report provides a strategic outlook of the cardiovascular devices market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
  • The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report. 
  • Analyst support through calls and email for timely clarification and incorporating additional requests. 
  • Option of presentation or doc format with the estimates file to take care of diverse requirements. 
  • 15% FREE customization with all our reports help cater additional requirements with significant cost-savings. 
  • Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

Cardiovascular Devices Market Scope:

Report Metric Details
Cardiovascular Devices Market Size in 2025 US$57.877 billion
Cardiovascular Devices Market Size in 2030 US$79.951 billion
Growth Rate CAGR of 6.68%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Billion
Segmentation
  • Device Type
  • Application
  • End-User
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Cardiovascular Devices Market
  • Abbott
  • Boston Scientific Corporation
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • Cardinal Health
Customization Scope Free report customization with purchase

 

Our Best-Performing Industry Reports:


Frequently Asked Questions (FAQs)

The cardiovascular devices market is expected to reach a total market size of US$79.951 billion by 2030.

Cardiovascular Devices Market is valued at US$57.877 billion in 2025.

The cardiovascular devices market is expected to grow at a CAGR of 6.68% during the forecast period.

The prime reason driving the cardiovascular device market growth is rising cases of cardiovascular diseases and their severity resulting in a surging death rate among patients.

The Asia Pacific cardiovascular market will grow at an exponential rate to increase its market share at a significant level, due to the growth in medical tourism in the region.

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE

5.1. Introduction

5.2. Stents

5.3. Pacemakers

5.4. Implantable Cardioverter-Defibrillators (ICDs)

5.5. Cardiac Resynchronization Therapy (CRT) Devices

5.6. Other Devices

6. CARDIOVASCULAR DEVICES MARKET BY APPLICATION

6.1. Introduction

6.2. Coronary Artery Diseases

6.3. Cardiac Arrhythmia

6.4. Heart Failure

6.5. Other Applications

7. CARDIOVASCULAR DEVICES MARKET BY END-USER 

7.1. Introduction

7.2. Hospitals

7.3. Specialty Clinics

7.4. Ambulatory Surgical Centers

7.5. Others

8. CARDIOVASCULAR DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. Japan

8.6.3. India

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Abbott 

10.2. Boston Scientific Corporation

10.3. Medtronic plc

10.4. Edwards Lifesciences Corporation

10.5. Cardinal Health

10.6. Terumo Corporation 

10.7. GE Healthcare 

10.8. Siemens Healthineers AG 

10.9. Johnson & Johnson

10.10. B. Braun SE 

10.11. Getinge AB

10.12. Koninklijke Philips N.V.

10.13. MicroPort Scientific Corporation 

10.14. Nihon Kohden Corporation 

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Abbott 

Boston Scientific Corporation

Medtronic plc

Edwards Lifesciences Corporation

Cardinal Health

Terumo Corporation 

GE Healthcare 

Siemens Healthineers AG 

Johnson & Johnson

B. Braun SE 

Getinge AB

Koninklijke Philips N.V.

MicroPort Scientific Corporation 

 Nihon Kohden Corporation